| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |






From the Fourth Department of Internal Medicine,* Kitasato University School of Medicine, Kanagawa, Japan; the Department of Cancer Research,
Division of Pathology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; the Department of Pathology,
Toho University School of Medicine, Tokyo, Japan; the Department of Pathology,
Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts; and the Department of Biochemistry and Molecular Biology,¶ School of Biomedical and Chemical Sciences, University of Western Australia, Crawley, Australia
Overexpression of CD30 is the hallmark of Hodgkin and Reed-Sternberg (H-RS) cells and drives constitutive nuclear factor-
B activation that is the molecular basis for the pathophysiology of Hodgkins lymphoma. Transcription of the CD30 gene is controlled by the core promoter that is driven by Sp-1 and the microsatellite sequences (MSs) that represses core promoter activity. To understand the mechanism(s) of CD30 overexpression in H-RS cells, we structurally and functionally characterized the CD30 MSs. Although the CD30 MS of H-RS cell lines was polymorphic, it was not truncated compared with that of control cells. A strong core promoter activity and constitutive Sp-1 binding were revealed in all cell lines examined irrespective of the levels of CD30 expression. In transient reporter gene assays, all MS clones derived from H-RS cell lines repressed the core promoter activity in unrelated cell lines, but not in the H-RS cell lines. An AP-1-binding site was found in the MS at nucleotide position of -377 to -371, the presence of which was found to relieve repression of the core promoter in H-RS cell lines but not in other tumor cell lines. H-RS cell lines showed constitutive and strong AP-1-binding activity, but other cell lines did not. The AP-1 complex contained JunB, whose overexpression activated reporter constructs driven by the CD30 promoter including the MSs, and was dependent on the AP-1 site. JunB expression was detected in H-RS cells in vitro and in vivo, but not in reactive cells or tumor cells of non-Hodgkins lymphoma of diffuse large B-cell type. Transduction of JunB small interfering RNAs suppressed CD30 promoter activity in L428 cells but not in control cells. Taken together, overexpression and binding of JunB to the AP-1 site appear to relieve the repression of the core promoter by the CD30 MS in H-RS cells, which provide one basis for the constitutive overexpression of CD30 in Hodgkins lymphoma.
This article has been cited by other articles:
![]() |
F. Y.-Y. Hsu, P. B. Johnston, K. A. Burke, and Y. Zhao The Expression of CD30 in Anaplastic Large Cell Lymphoma Is Regulated by Nucleophosmin-Anaplastic Lymphoma Kinase-Mediated JunB Level in a Cell Type-Specific Manner. Cancer Res., September 15, 2006; 66(18): 9002 - 9008. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ebersole, Y. Okamoto, V. N. Noskov, N. Kouprina, J.-H. Kim, S.-H. Leem, J. C. Barrett, H. Masumoto, and V. Larionov Rapid generation of long synthetic tandem repeats and its application for analysis in human artificial chromosome formation Nucleic Acids Res., September 1, 2005; 33(15): e130 - e130. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Watanabe, M. Sasaki, K. Itoh, M. Higashihara, K. Umezawa, M. E. Kadin, L. J. Abraham, T. Watanabe, and R. Horie JunB Induced by Constitutive CD30-Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinase Signaling Activates the CD30 Promoter in Anaplastic Large Cell Lymphoma and Reed-Sternberg Cells of Hodgkin Lymphoma Cancer Res., September 1, 2005; 65(17): 7628 - 7634. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imamura, C. Imamura, Y. Iwamoto, and L. J. Sandell Transcriptional Co-activators CREB-binding Protein/p300 Increase Chondrocyte Cd-rap Gene Expression by Multiple Mechanisms Including Sequestration of the Repressor CCAAT/Enhancer-binding Protein J. Biol. Chem., April 29, 2005; 280(17): 16625 - 16634. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |